Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Neurologic Manifestations
×
Temozolomide
×
Clear all
Filters
3
NCT01120639
2021-08-06
Tx-Treatment
Stanford University
Phase 1/2
Completed
30 enrolled
19 charts